| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 166.819 | 191.075 | 245.370 | 255.335 | 350.457 | 403.050 | 452.512 | 488.698 | 584.133 | 3.118.731 |
| Total Income - EUR | 166.820 | 191.076 | 245.371 | 255.335 | 350.459 | 406.084 | 454.542 | 488.700 | 586.152 | 3.118.876 |
| Total Expenses - EUR | 161.055 | 179.383 | 214.736 | 239.773 | 282.189 | 351.153 | 388.385 | 404.886 | 473.101 | 2.511.566 |
| Gross Profit/Loss - EUR | 5.765 | 11.693 | 30.636 | 15.562 | 68.271 | 54.930 | 66.158 | 83.814 | 113.051 | 607.310 |
| Net Profit/Loss - EUR | 4.038 | 8.948 | 28.311 | 13.270 | 65.009 | 50.869 | 62.104 | 79.459 | 104.669 | 476.155 |
| Employees | 17 | 18 | 17 | 19 | 18 | 18 | 19 | 19 | 20 | 20 |
Check the financial reports for the company - Nicomed Impex S.r.l.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 29.133 | 54.160 | 77.005 | 66.928 | 77.288 | 62.471 | 85.329 | 68.107 | 116.681 | 586.405 |
| Current Assets | 5.312 | 9.406 | 5.214 | 13.937 | 11.707 | 32.751 | 25.165 | 51.565 | 67.275 | 336.894 |
| Inventories | 743 | 6.270 | 985 | 4.952 | 662 | 12.223 | 15.201 | 17.658 | 11.784 | 22.291 |
| Receivables | 0 | 0 | 0 | 1.372 | 800 | 2.318 | 3.810 | 0 | 0 | 8.298 |
| Cash | 4.569 | 3.136 | 4.230 | 7.613 | 10.246 | 18.209 | 6.154 | 33.908 | 55.491 | 306.305 |
| Shareholders Funds | 24.961 | 33.486 | 46.195 | 48.034 | 72.621 | 58.307 | 69.925 | 80.833 | 106.035 | 482.949 |
| Social Capital | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 | 400 |
| Debts | 9.484 | 31.701 | 36.794 | 33.037 | 16.374 | 36.914 | 42.605 | 39.969 | 84.780 | 457.523 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 1 | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Nicomed Impex S.r.l.